(Q34571953)

3 August 2017

1 reference

title

Hepatic-arterial chemotherapy (English)

1 reference

3 August 2017

1 reference

N Kemeny

1

1 reference

3 August 2017

F Fata

series ordinal

2

1 reference

3 August 2017

publication date

1 July 2001

1 reference

Lancet Oncology Commission

3 August 2017

published in

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

7

1 reference

3 August 2017

page(s)

418-428

1 reference

Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Tumor and liver drug uptake following hepatic artery and portal vein infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Regional infusion for colorectal hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Pharmacologic rationale for regional drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Unchanged pharmacokinetics of etoposide given by intra-arterial hepatic infusion as compared with i.v. infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Differential device performances for hepatic arterial chemotherapy: a technical report on totally implantable pumps and ports for both continuous and bolus infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Hepatic artery access ports: recognizing and avoiding the problems.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Transcatheter embolization for the treatment of misperfusion after hepatic artery chemoinfusion pump implantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Regional chemotherapy devices: effect of experience and anatomy on complications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Prognostic factors in patients with liver metastases from colorectal carcinoma treated with discontinuous intra-arterial hepatic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

The regional treatment of liver metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Arterial infusion chemotherapy for advanced hepatocellular carcinoma using EPF and EAP therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Intrahepatic chemotherapy for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Multimodality cisplatin treatment in nonresectable alpha-fetoprotein-positive hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Use of intrahepatic chemotherapy to treat advanced pediatric hepatic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases. Meta-Analysis Group In Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Liver resection for colorectal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Factors influencing the natural history of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Phase II trial of irinotecan in patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Regional chemotherapy of colorectal cancer metastatic to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Regional hepatic chemotherapy using an implantable drug infusion pump

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Assessment of treatment of intrahepatic malignancies using chemotherapy via an implantable pump

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Sclerosing cholangitis after continuous hepatic artery infusion of FUDR

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedule for liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Waiting for the definitive trial of hepatic arterial chemotherapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900419-8

7 January 2021

10.1016/S1470-2045(00)00419-8

Identifiers

DOI

1 reference

3 August 2017

1 reference